We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+30.89%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$331M
AUM Growth
+$38.2M
Cap. Flow
-$22.9M
Cap. Flow %
-6.92%
Top 10 Hldgs %
73.74%
Holding
44
New
9
Increased
8
Reduced
11
Closed
8

Top Buys

Rank Stock Value
1
AVXS
AveXis, Inc. Common Stock
AVXS
+$13.3M
2
AGEN
Agenus
AGEN
+$10M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.17M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$7.86M
5
ARWR icon
Arrowhead Research
ARWR
+$7.24M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$29.3M
2
INCY icon
Incyte
INCY
+$16.9M
3
KITE
Kite Pharma, Inc.
KITE
+$14.3M
4
SSRG
SYMMETRY SURGICAL INC COMMON STK
SSRG
+$12.1M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$6.25M

Sector Composition

Rank Sector Weight
1 Healthcare 90.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
26
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.21M 0.67%
95,714
-1,424
-1% -$27.1K
MASI
27
DELISTED
Masimo
MASI
$1.54M 0.47%
25,900
– –
NVAX icon
28
CALL
Novavax
NVAX
$1.22B
$996K 0.3%
+239
New +$30.9K
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$854K 0.26%
129,129
-1,923
-1% -$10.2K
SRTS icon
30
Sensus Healthcare
SRTS
$48.1M
$773K 0.23%
+125,700
New +$787K
TMBR
31
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$389K 0.12%
47
– –
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
$356K 0.11%
+20,000
New +$304K
NTRA icon
33
Natera
NTRA
$38.7B
$352K 0.11%
31,693
– –
MNKD icon
34
PUT
MannKind Corp
MNKD
$1.17B
$272K 0.08%
877
– –
ALPN
35
DELISTED
Alpine Immune Sciences Inc
ALPN
$244K 0.07%
7,500
– –
ABEO icon
36
Abeona Therapeutics
ABEO
$364M
$116K 0.04%
+776
New +$75.9K
AXDX
37
DELISTED
Accelerate Diagnostics
AXDX
– –
-7,484
Closed -$1.08M
TLT icon
38
iShares 20+ Year Treasury Bond ETF
TLT
$41.4B
– –
-45,000
Closed -$6.25M
MDRX
39
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-48,000
Closed -$610K
ICPT
40
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-39,500
Closed -$5.64M
KITE
41
DELISTED
Kite Pharma, Inc.
KITE
– –
-285,518
Closed -$14.3M
CYTR
42
DELISTED
CytRx Corp
CYTR
– –
-77,700
Closed -$1.04M
SSRG
43
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
– –
-922,215
Closed -$12.1M
1
2

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

RTW Investments's Q3 2016 Portfolio in Review

As of Q3 2016, RTW Investments held 44 positions worth $331M, up 13% from $293M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

RTW Investments withdrew a net $22.9M in Q3 2016, closing 8 positions and reducing 11 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $14.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 81% a quarter earlier.

Against the trend, RTW Investments opened a new position in Arrowhead Research worth $8.21M.

  • RTW Investments's largest Q3 2016 buy was Arrowhead Research: 1,116,777 shares worth $8.21M.
  • RTW Investments added most to AveXis, Inc. Common Stock in Q3 2016, an estimated $13.3M increase.
  • RTW Investments's biggest Q3 2016 reduction was bluebird bio, cutting an estimated $29.3M.
  • RTW Investments fully exited Kite Pharma, Inc. in Q3 2016, selling an estimated $14.3M.
  • RTW Investments's ten largest holdings make up 74% of its $331M portfolio in Q3 2016.
  • RTW Investments opened 9 new positions and closed 8 in Q3 2016.
  • RTW Investments's portfolio value rose 13% quarter-over-quarter to $331M.

Based on RTW Investments's 13F filing for Q3 2016, filed 14 Nov 2016.